News
-
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Onco-Innovations signs LOI with Ifowonco Informatics to explore LAG-3 Program collaboration for enhanced anti-tumour immune responses in cancer therapy -
-
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / News release on accounts, results
-
-
-